Form 4 Tracker
William E. Rote

Chief Research Officer · 5 filings · Latest: Sep 15, 2026

Travere Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TVTX
William E. RoteChief Research OfficerSep 16, 2026
Sale
$63.33112,850$7.1M98,197
TVTX
William E. RoteChief Research OfficerSep 16, 2026
Option Exercise
$21.29112,850$2.4M211,047
TVTX
William E. RoteChief Research OfficerSep 15, 2026
Sale
$62.2596,198$6.0M98,197
TVTX
William E. RoteChief Research OfficerSep 15, 2026
Option Exercise
$21.5778,650$1.7M194,395
TVTX
WILLIAM ROTE—Sep 16, 2026
Proposed Sale
$62.51112,850$7.1M—
TVTX
WILLIAM ROTE—Sep 15, 2026
Proposed Sale
$65.7996,198$6.3M—
TVTX
William E. RoteChief Research OfficerMay 6, 2026
Sale
$43.952,763$121.4K115,474
TVTX
William E. RoteChief Research OfficerMay 4, 2026
Option Exercise
$0.004,250—118,237
TVTX
ROTE WILLIAM E.—May 6, 2026
Proposed Sale
$43.952,763$121.4K—
TVTX
William E. RoteChief Research OfficerApr 22, 2026
Sale
$39.099,100$355.7K113,987
TVTX
ROTE WILLIAM E.—Apr 22, 2026
Proposed Sale
$39.099,100$355.7K—
TVTX
William E. RoteChief Research OfficerFeb 3, 2026
Sale
$32.8712,446$409.1K109,087
TVTX
ROTE WILLIAM E.—Feb 3, 2026
Proposed Sale
$32.8712,446$409.1K—
TVTX
ROTE WILLIAM E.—Dec 24, 2025
Proposed Sale
$40.1060,000$2.4M—
TVTX
ROTE WILLIAM E.—May 5, 2025
Proposed Sale
$21.053,198$67.3K—
TVTX
ROTE WILLIAM E.—Feb 12, 2025
Proposed Sale
$23.535,200$122.4K—
TVTX
ROTE WILLIAM E.—Feb 3, 2025
Proposed Sale
$19.788,951$177.1K—
TVTX
ROTE WILLIAM E.—Jan 22, 2025
Proposed Sale
$19.462,437$47.4K—
TVTX
ROTE WILLIAM E.—Sep 9, 2024
Proposed Sale
$11.524,387$50.5K—